NBP insider buying
NovaBridge Biosciences
Every qualifying open-market purchase of NBP reported to the SEC on Form 4, parsed directly from the filings and linked back to the source on EDGAR. No buying cluster — two or more distinct insiders inside a rolling window — has been detected in NBP yet; if one forms, it appears here (and hits our alert subscribers in real time).
All notable open-market buys in NBP
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Apr 24, 2026 | See Remarks | 230,000 | $2.51 | $577.3K | SEC ↗ |
NBP insider buying — FAQ
- Are insiders buying NBP stock?
- 1 insider has bought NBP (NovaBridge Biosciences) on the open market, most recently on Apr 28, 2026. No cluster buy — two or more distinct insiders within a rolling window — has been detected yet.
- How much NBP stock have insiders bought?
- Insiders have bought a combined $577.3K of NBP across 1 open-market purchase, based on SEC Form 4 filings.
- What is an insider cluster buy in NBP?
- A cluster buy is two or more distinct NovaBridge Biosciences insiders — officers, directors, or 10% owners — each buying NBP on the open market within a rolling window. None has been detected in NBP yet.
- Where does this NBP insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in NBP
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy NBP within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding NBP.